Log in
Enquire now
Diagnomics

Diagnomics

Diagnomics is a San Diego-based company developing next generation sequencing-based genomics founded in 2011.

OverviewStructured DataIssuesContributors

Contents

diagnomics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Molecular diagnostics
Molecular diagnostics
Biomedical engineering
Biomedical engineering
Genetics
Genetics
Genomics
Genomics
Technology
Technology
Biology
Biology
...
Location
Valhalla, New York
Valhalla, New York
San Diego
San Diego
B2X
B2C
B2C
CEO
Min Seob Lee
Min Seob Lee
Founder
Min Seob Lee
Min Seob Lee
‌
Stefan Gruenwald
Legal Name
Diagnomics, Inc.
Legal classification
Corporation
Corporation
Number of Employees (Ranges)
1 – 10
Email Address
Full Address
9305 Lightwave Ave Ste 100 San Diego​, CA, 92123-6461 United States
DUNS Number
060613086
Founded Date
January 1, 2011
Latest Funding Type
‌
Corporate funding round
Country
United States
United States

Other attributes

Company Operating Status
Active
Funding Round Date
December 19, 2019

Diagnomics was established by Min Seob Lee and provides a software platform for next generation genomics sequencing and polymerase chain reaction. It uses its software to develop diagnostic tools and resources for personalized healthcare. These resources are available to academic institutions and biotech and pharmaceutical companies.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Diagnomics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.